Industries > Pharma > Global Live Vaccines Market Forecast 2020-2030

Global Live Vaccines Market Forecast 2020-2030

Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others PLUS analysis on leading companies in the Live Vaccines Market

PUBLISHED: 12 March 2020
PAGES: 213
PRODUCT CODE: PHA0725
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

covid-19

The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn by 2030. In 2019, the North American segment held 39% of the global live vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 213-page report you will receive 138 tables and 65 figures– all unavailable elsewhere.

The 213-page report provides clear detailed insight into the live vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Live Vaccines Market from 2020-2030

Global Live Vaccines Market Forecast 2020-2030

• Forecast of the Global Live Vaccines Market by Type of Product:
• Bacterial
• Viral

• Forecast of the Global Live Vaccines Market by Indication:
• Oral Polio Vaccine (OPV)
• Measles
• Rotavirus
• Tuberculosis
• Yellow Fever
• Others

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Mexico

• Our study discusses the selected leading companies that are the major players in the live vaccines market:
• AstraZeneca
• Bavarian Nordic A/S
• DAIICHI SANKYO COMPANY, LIMITED
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc
• Inovio Pharmaceuticals, Inc.
• & Other Companies

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the SWOT & PEST Analyses of the live vaccines market.

Visiongain’s study is intended for anyone requiring commercial analyses for the live vaccines market. You find data, trends and predictions.

Buy our report today Global Live Vaccines Market Forecast 2020-2030: Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category